Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

SARS and common viral infections.

Janice K Louie1, Jill K Hacker, Jennifer Mark

  • 1California Emerging Infections Program, California Department of Health Services, Berkeley, 94704, USA. JLouie@dhs.ca.gov

Emerging Infectious Diseases
|June 23, 2004
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcomes and Treatment-limiting Adverse Events of Patients Receiving BPaL and BPaL-FQ in California.

Open forum infectious diseases·2026
Same author

Dermacentor occidentalis Ticks and Link to Rickettsia lanei Infections, California, USA.

Emerging infectious diseases·2026
Same author

Detection of Community Transmission of Clade Ib Mpox Virus in the United States.

NEJM evidence·2025
Same author

Experience with Linezolid for the Treatment of Rifampin-Susceptible Tuberculosis in San Francisco.

Open forum infectious diseases·2025
Same author

Feasibility of rapid low dose buprenorphine initiation in an emergency department observation unit.

The American journal of emergency medicine·2025
Same author

Tuberculosis Infection Screening Recommendations for Targeted Immunotherapies: Comparison of US Prescribing Information, Clinical Resources, and Quality Measures.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2025

Molecular testing effectively reduced suspicion for severe acute respiratory syndrome (SARS) by identifying common respiratory pathogens in California patients. This diagnostic approach proved valuable in cases of both suspected and probable SARS.

Area of Science:

  • Infectious Diseases
  • Molecular Diagnostics
  • Public Health

Background:

  • Severe acute respiratory syndrome (SARS) posed a significant public health concern.
  • Accurate and rapid diagnostics are crucial for managing respiratory infections.

Purpose of the Study:

  • To evaluate the utility of molecular testing in diagnosing severe acute respiratory syndrome (SARS).
  • To identify common respiratory pathogens in patients with suspected or probable SARS.

Main Methods:

  • Molecular testing was performed on patients in California with suspected or probable SARS.
  • The tests detected a range of common respiratory pathogens.

Main Results:

  • Molecular testing identified pathogens in 45% of suspected SARS cases (23/51).

Related Experiment Videos

  • Pathogens were detected in 47% of probable SARS cases (9/19).
  • Commonly detected pathogens included influenza A/B, human metapneumovirus, and others.

    • Conclusions:

    • Molecular testing is a useful tool for reducing suspicion of SARS.
    • The detection of common respiratory pathogens aids in differential diagnosis.